Log in
Log into your PedsMrkt account to access our Community forums.
If you don't see an email, please check your Junk folder. The email will be sent from support@pedsmrkt.com
IP License - Lactoferrin for Potential Prevention Against Neonatal Sepsis
IP Licensing
For informational purposes only. Please contact seller directly for more details.
Share This:
Prenatal maternal vaginal administration of lactoferrin (LF) significantly decreases vaginal bacterial loads of a clinically significant neonatal invasive E. coli isolate. Placental bacterial loads, and burden of infection in the offspring were also significantly decreased. Prenatal lactoferrin is a potential preventative intervention against neonatal sepsis. Patent Pending.
Resources
Shipping Information
Digital delivery/downloads will typically be delivered within 2 business days.
Add to Cart: Physical products typically take 5-8 business days. You will receive an order confirmation email from PedsMrkt followed by a shipping email when your order ships.
Please contact the seller directly with any questions about your order.
Returns
Please contact the seller directly for their return policy and to
handle returns. Customer will be responsible for return shipping fees.
